feed,title,long_url,short_url
FDA:MedWatch,FDA Requires Guillain-Barr√© Syndrome (GBS) Warning in the Prescribing Information for RSV Vaccines Abrysvo and Arexvy: FDA Safety Communication,http://www.fda.gov/safety/medical-product-safety-information/fda-requires-guillain-barre-syndrome-gbs-warning-prescribing-information-rsv-vaccines-abrysvo-and,https://da.gd/Maw1mo
